UPCDC-30245 is an allosteric p97 inhibitor with an IC 50 of approximately 27 nM UPCDC-30245 inhibits the p97 mutant N660K similar to wild type (WT; IC 50 =300 nM) and shows 3-fold resistance for p97 mutant T688A . UPCDC-30245 can be used in the research of cancer In Vitro UPCDC-30245 binds at the junction between the D1 dan D2 domains of p97. UPCDC-30245 inhibits cell proliferation in HeLa, A549, BxPC-3, PRMI8226, MM1S, HCT116 cells, and appears more potent in HT29 cells. UPCDC-30245 (0.01-100 μM) shows anti-proliferative effects on parental and CB-5083 resistant HCT116 cell lines that harbor a new p97 double mutation (D649A/T688A). UPCDC-30245 (4 μm; 2, 6, 10, 18, 24 hours; functional enrichment analysis) is not linked to pathways typically impacted by p97 inhibition, such as protein processing in the ER, UPR, and asparagine N-linked glycosylation. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:allosteric p97|27 nM (IC|50|)|wild type p97|300 nM (IC|50|)
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
UPCDC-30245
CAS number：1883351-01-6 molecular formula：C28H38FN5
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 1883351-01-6 | molecular formula | C28H38FN5 |
| molecular weight | 463.63 g/mol | Exact mass | ≥99% |
| PSA | 37.500 Ų | logp | 4.700 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
